AxoGen, Inc. (AXGN)
USD 16.14
(-5.28%)
USD 16.14
(-5.28%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 196.82 Million USD | 0.74% |
| 2022 | 195.38 Million USD | -6.07% |
| 2021 | 208.02 Million USD | 3.3% |
| 2020 | 201.38 Million USD | 30.22% |
| 2019 | 154.64 Million USD | -3.45% |
| 2018 | 160.17 Million USD | 172.06% |
| 2017 | 58.87 Million USD | 26.99% |
| 2016 | 46.36 Million USD | 23.48% |
| 2015 | 37.54 Million USD | 128.93% |
| 2014 | 16.4 Million USD | -40.76% |
| 2013 | 27.68 Million USD | 36.84% |
| 2012 | 20.23 Million USD | 61.91% |
| 2011 | 12.49 Million USD | 23.18% |
| 2010 | 10.14 Million USD | -39.65% |
| 2009 | 16.8 Million USD | 3106.23% |
| 2008 | 524.24 Thousand USD | -52.34% |
| 2007 | 1.09 Million USD | -27.38% |
| 2006 | 1.51 Million USD | -17.0% |
| 2005 | 1.82 Million USD | -34.9% |
| 2004 | 2.8 Million USD | 4.18% |
| 2003 | 2.69 Million USD | -35.17% |
| 2002 | 4.15 Million USD | -34.64% |
| 2001 | 6.35 Million USD | -25.07% |
| 2000 | 8.47 Million USD | -16.09% |
| 1999 | 10.1 Million USD | -10.62% |
| 1998 | 11.3 Million USD | -4.24% |
| 1997 | 11.8 Million USD | -4.07% |
| 1996 | 12.3 Million USD | -3.15% |
| 1995 | 12.7 Million USD | 2.42% |
| 1994 | 12.4 Million USD | 12.73% |
| 1993 | 11 Million USD | 11.11% |
| 1992 | 9.9 Million USD | 17.86% |
| 1991 | 8.4 Million USD | 0.0% |
| 1990 | 8.4 Million USD | 2.44% |
| 1989 | 8.2 Million USD | 18.84% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 188.93 Million USD | 1.3% |
| 2024 Q1 | 186.51 Million USD | -5.24% |
| 2023 Q1 | 189.47 Million USD | -3.03% |
| 2023 Q4 | 196.82 Million USD | 1.13% |
| 2023 Q3 | 194.63 Million USD | 1.56% |
| 2023 FY | 196.82 Million USD | 0.74% |
| 2023 Q2 | 191.64 Million USD | 1.14% |
| 2022 FY | 195.38 Million USD | -6.07% |
| 2022 Q1 | 198.02 Million USD | -4.81% |
| 2022 Q4 | 195.38 Million USD | -0.07% |
| 2022 Q3 | 195.52 Million USD | -0.29% |
| 2022 Q2 | 196.08 Million USD | -0.98% |
| 2021 Q2 | 210.53 Million USD | 6.67% |
| 2021 Q4 | 208.02 Million USD | -0.93% |
| 2021 FY | 208.02 Million USD | 3.3% |
| 2021 Q1 | 197.36 Million USD | -1.99% |
| 2021 Q3 | 209.97 Million USD | -0.27% |
| 2020 FY | 201.38 Million USD | 30.22% |
| 2020 Q1 | 144.88 Million USD | -6.31% |
| 2020 Q2 | 169.96 Million USD | 17.31% |
| 2020 Q3 | 193.93 Million USD | 14.11% |
| 2020 Q4 | 201.38 Million USD | 3.84% |
| 2019 Q1 | 160.49 Million USD | 0.2% |
| 2019 Q2 | 156.6 Million USD | -2.42% |
| 2019 Q3 | 154.19 Million USD | -1.54% |
| 2019 Q4 | 154.64 Million USD | 0.29% |
| 2019 FY | 154.64 Million USD | -3.45% |
| 2018 Q4 | 160.17 Million USD | -0.92% |
| 2018 Q3 | 161.65 Million USD | 0.69% |
| 2018 Q2 | 160.54 Million USD | 191.0% |
| 2018 Q1 | 55.17 Million USD | -6.29% |
| 2018 FY | 160.17 Million USD | 172.06% |
| 2017 Q3 | 42.22 Million USD | -1.26% |
| 2017 FY | 58.87 Million USD | 26.99% |
| 2017 Q4 | 58.87 Million USD | 39.42% |
| 2017 Q2 | 42.76 Million USD | -1.17% |
| 2017 Q1 | 43.27 Million USD | -6.66% |
| 2016 Q3 | 30.77 Million USD | -3.08% |
| 2016 Q1 | 33.49 Million USD | -10.78% |
| 2016 FY | 46.36 Million USD | 23.48% |
| 2016 Q4 | 46.36 Million USD | 50.65% |
| 2016 Q2 | 31.75 Million USD | -5.21% |
| 2015 Q3 | 40.91 Million USD | 60.93% |
| 2015 Q2 | 25.42 Million USD | -9.64% |
| 2015 Q1 | 28.13 Million USD | 71.55% |
| 2015 FY | 37.54 Million USD | 128.93% |
| 2015 Q4 | 37.54 Million USD | -8.23% |
| 2014 FY | 16.4 Million USD | -40.76% |
| 2014 Q3 | 20.09 Million USD | -10.28% |
| 2014 Q2 | 22.39 Million USD | -8.83% |
| 2014 Q1 | 24.56 Million USD | -11.26% |
| 2014 Q4 | 16.4 Million USD | -18.39% |
| 2013 Q4 | 27.68 Million USD | -6.99% |
| 2013 Q3 | 29.76 Million USD | 89.91% |
| 2013 Q2 | 15.67 Million USD | -12.21% |
| 2013 Q1 | 17.85 Million USD | -11.76% |
| 2013 FY | 27.68 Million USD | 36.84% |
| 2012 FY | 20.23 Million USD | 61.91% |
| 2012 Q4 | 20.23 Million USD | 108.7% |
| 2012 Q3 | 9.69 Million USD | -1.46% |
| 2012 Q2 | 9.83 Million USD | -6.1% |
| 2012 Q1 | 10.47 Million USD | -16.15% |
| 2011 Q1 | 11.37 Million USD | 12.1% |
| 2011 Q2 | 12.16 Million USD | 6.95% |
| 2011 Q3 | 14.44 Million USD | 18.76% |
| 2011 Q4 | 12.49 Million USD | -13.48% |
| 2011 FY | 12.49 Million USD | 23.18% |
| 2010 Q1 | 11.32 Million USD | -32.64% |
| 2010 FY | 10.14 Million USD | -39.65% |
| 2010 Q4 | 10.14 Million USD | -2.51% |
| 2010 Q3 | 10.4 Million USD | -3.54% |
| 2010 Q2 | 10.78 Million USD | -4.72% |
| 2009 Q2 | 734.6 Thousand USD | 68.34% |
| 2009 Q3 | 455.96 Thousand USD | -37.93% |
| 2009 Q4 | 16.8 Million USD | 3586.32% |
| 2009 FY | 16.8 Million USD | 3106.23% |
| 2009 Q1 | 436.38 Thousand USD | -16.76% |
| 2008 Q2 | 795.49 Thousand USD | -19.33% |
| 2008 Q4 | 524.24 Thousand USD | -18.32% |
| 2008 Q1 | 986.15 Thousand USD | -10.35% |
| 2008 FY | 524.24 Thousand USD | -52.34% |
| 2008 Q3 | 641.82 Thousand USD | -19.32% |
| 2007 Q4 | 1.09 Million USD | -2.87% |
| 2007 FY | 1.09 Million USD | -27.38% |
| 2007 Q1 | 1.43 Million USD | -5.17% |
| 2007 Q2 | 1.23 Million USD | -13.85% |
| 2007 Q3 | 1.13 Million USD | -8.49% |
| 2006 Q3 | 1.61 Million USD | -4.79% |
| 2006 Q4 | 1.51 Million USD | -6.5% |
| 2006 FY | 1.51 Million USD | -17.0% |
| 2006 Q2 | 1.7 Million USD | -4.98% |
| 2006 Q1 | 1.79 Million USD | -1.87% |
| 2005 FY | 1.82 Million USD | -34.9% |
| 2005 Q2 | 1.78 Million USD | -8.45% |
| 2005 Q3 | 1.74 Million USD | -2.02% |
| 2005 Q4 | 1.82 Million USD | 4.32% |
| 2005 Q1 | 1.94 Million USD | -30.44% |
| 2004 Q2 | 2.41 Million USD | -2.0% |
| 2004 FY | 2.8 Million USD | 4.18% |
| 2004 Q4 | 2.8 Million USD | -25.03% |
| 2004 Q3 | 3.73 Million USD | 54.9% |
| 2004 Q1 | 2.46 Million USD | -8.45% |
| 2003 FY | 2.69 Million USD | -35.17% |
| 2003 Q4 | 2.69 Million USD | -2.57% |
| 2003 Q1 | 3.05 Million USD | -26.3% |
| 2003 Q2 | 3.05 Million USD | -0.11% |
| 2003 Q3 | 2.76 Million USD | -9.61% |
| 2002 Q1 | 5.64 Million USD | 0.0% |
| 2002 Q2 | 5.21 Million USD | -7.54% |
| 2002 Q3 | 4.64 Million USD | -11.04% |
| 2002 Q4 | 4.15 Million USD | -10.59% |
| 2002 FY | 4.15 Million USD | -34.64% |
| 2001 Q2 | 9.96 Million USD | 29.75% |
| 2001 Q3 | 8.08 Million USD | -18.88% |
| 2001 FY | 6.35 Million USD | -25.07% |
| 2001 Q1 | 7.68 Million USD | -8.11% |
| 2000 Q4 | 8.36 Million USD | 1.53% |
| 2000 Q3 | 8.23 Million USD | -2.84% |
| 2000 Q2 | 8.47 Million USD | -10.19% |
| 2000 Q1 | 9.43 Million USD | 7.23% |
| 2000 FY | 8.47 Million USD | -16.09% |
| 1999 Q4 | 8.8 Million USD | -8.33% |
| 1999 Q1 | 10.3 Million USD | -2.83% |
| 1999 Q2 | 10.1 Million USD | -1.94% |
| 1999 Q3 | 9.6 Million USD | -4.95% |
| 1999 FY | 10.1 Million USD | -10.62% |
| 1998 Q3 | 11.2 Million USD | -0.88% |
| 1998 Q1 | 12 Million USD | -2.44% |
| 1998 Q2 | 11.3 Million USD | -5.83% |
| 1998 FY | 11.3 Million USD | -4.24% |
| 1998 Q4 | 10.6 Million USD | -5.36% |
| 1997 Q1 | 11.6 Million USD | -5.69% |
| 1997 FY | 11.8 Million USD | -4.07% |
| 1997 Q2 | 11.8 Million USD | 1.72% |
| 1997 Q3 | 12.4 Million USD | 5.08% |
| 1997 Q4 | 12.3 Million USD | -0.81% |
| 1996 FY | 12.3 Million USD | -3.15% |
| 1996 Q4 | 12.3 Million USD | -0.81% |
| 1996 Q3 | 12.4 Million USD | 0.81% |
| 1996 Q1 | 12.6 Million USD | 1.61% |
| 1996 Q2 | 12.3 Million USD | -2.38% |
| 1995 Q3 | 12.9 Million USD | 1.57% |
| 1995 Q1 | 12.9 Million USD | 1.57% |
| 1995 Q2 | 12.7 Million USD | -1.55% |
| 1995 Q4 | 12.4 Million USD | -3.88% |
| 1995 FY | 12.7 Million USD | 2.42% |
| 1994 Q2 | 12.4 Million USD | 3.33% |
| 1994 Q3 | 12.6 Million USD | 1.61% |
| 1994 FY | 12.4 Million USD | 12.73% |
| 1994 Q1 | 12 Million USD | -1.64% |
| 1994 Q4 | 12.7 Million USD | 0.79% |
| 1993 Q4 | 12.2 Million USD | 2.52% |
| 1993 Q2 | 11 Million USD | 0.92% |
| 1993 Q1 | 10.9 Million USD | 4.81% |
| 1993 FY | 11 Million USD | 11.11% |
| 1993 Q3 | 11.9 Million USD | 8.18% |
| 1992 FY | 9.9 Million USD | 17.86% |
| 1992 Q2 | 9.9 Million USD | 1.02% |
| 1992 Q4 | 10.4 Million USD | 0.0% |
| 1992 Q1 | 9.8 Million USD | 3.16% |
| 1992 Q3 | 10.4 Million USD | 5.05% |
| 1991 Q4 | 9.5 Million USD | 5.56% |
| 1991 FY | 8.4 Million USD | 0.0% |
| 1991 Q3 | 9 Million USD | 7.14% |
| 1991 Q2 | 8.4 Million USD | -6.67% |
| 1991 Q1 | 9 Million USD | 7.14% |
| 1990 Q2 | 8.4 Million USD | -85.39% |
| 1990 Q1 | 57.5 Million USD | -1.2% |
| 1990 FY | 8.4 Million USD | 2.44% |
| 1990 Q4 | 8.4 Million USD | 1.2% |
| 1990 Q3 | 8.3 Million USD | -1.19% |
| 1989 Q3 | 8.5 Million USD | 3.66% |
| 1989 FY | 8.2 Million USD | 18.84% |
| 1989 Q2 | 8.2 Million USD | 0.0% |
| 1989 Q4 | 58.2 Million USD | 584.71% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -527.517% |
| BrainsWay Ltd. | 62.97 Million USD | -212.563% |
| Cerus Corporation | 197.74 Million USD | 0.466% |
| Envoy Medical, Inc. | 7.64 Million USD | -2476.27% |
| electroCore, Inc. | 16.38 Million USD | -1101.117% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -2458.853% |
| IceCure Medical Ltd | 16.41 Million USD | -1099.433% |
| Inogen, Inc. | 326.19 Million USD | 39.66% |
| OrthoPediatrics Corp. | 449.58 Million USD | 56.22% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -621.771% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -1087.206% |
| MaxCyte, Inc. | 268.27 Million USD | 26.632% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -2330.769% |
| Nexalin Technology, Inc. | 3.63 Million USD | -5319.371% |
| Orthofix Medical Inc. | 925.31 Million USD | 78.729% |
| PAVmed Inc | 33.11 Million USD | -494.302% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -37.208% |
| RxSight, Inc. | 182.55 Million USD | -7.821% |
| Sight Sciences, Inc. | 166.65 Million USD | -18.107% |
| SI-BONE, Inc. | 230.42 Million USD | 14.581% |
| TELA Bio, Inc. | 78.04 Million USD | -152.187% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 21.865% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -1734.362% |
| Acutus Medical, Inc. | 53.96 Million USD | -264.765% |
| Talis Biomedical Corporation | 98.34 Million USD | -100.149% |
| Spectral AI, Inc. | 10.69 Million USD | -1740.881% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 9.98% |
| CVRx, Inc. | 115.22 Million USD | -70.814% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -235.533% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -6218.171% |
| Bioventus Inc. | 810.91 Million USD | 75.728% |
| Venus Concept Inc. | 93.65 Million USD | -110.164% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -665.12% |
| LivaNova PLC | 2.42 Billion USD | 91.899% |
| 908 Devices Inc. | 202.98 Million USD | 3.032% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 75.556% |
| Nemaura Medical Inc. | 14.56 Million USD | -1251.534% |
| NeuroPace, Inc. | 107.65 Million USD | -82.838% |
| LENSAR, Inc. | 69.58 Million USD | -182.858% |
| Apyx Medical Corporation | 79.24 Million USD | -148.393% |
| Cutera, Inc. | 346.29 Million USD | 43.161% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -368.457% |
| BioSig Technologies, Inc. | 1.79 Million USD | -10846.997% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 27.271% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -361.375% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 94.796% |
| Axonics, Inc. | 719.92 Million USD | 72.66% |
| Outset Medical, Inc. | 313.8 Million USD | 37.276% |
| IRIDEX Corporation | 34.43 Million USD | -471.573% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 51.367% |
| IRadimed Corporation | 92.15 Million USD | -113.58% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -3646.231% |
| INVO Bioscience, Inc. | 20.88 Million USD | -842.307% |
| Telesis Bio, Inc. | 70.41 Million USD | -179.54% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -27.725% |
| Varex Imaging Corporation | 1.24 Billion USD | 84.249% |
| Quipt Home Medical Corp. | 247.4 Million USD | 20.444% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2014.146% |
| Pulmonx Corporation | 178.95 Million USD | -9.989% |
| Dynatronics Corporation | 25.94 Million USD | -658.762% |
| Modular Medical, Inc. | 13.8 Million USD | -1325.559% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -1734.875% |
| Semler Scientific, Inc. | 78.06 Million USD | -152.132% |
| InMode Ltd. | 863.28 Million USD | 77.2% |
| Bruker Corporation | 4.24 Billion USD | 95.369% |
| Cytosorbents Corporation | 53.26 Million USD | -269.554% |
| DexCom, Inc. | 6.26 Billion USD | 96.858% |
| Align Technology, Inc. | 6.08 Billion USD | 96.765% |
| Viveve Medical, Inc. | 25.91 Million USD | -659.569% |
| ZimVie Inc. | 1.2 Billion USD | 83.67% |
| Movano Inc. | 9.42 Million USD | -1989.237% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 60.45% |
| Nexalin Technology, Inc. | 3.63 Million USD | -5319.371% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -235.533% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 79.339% |
| Profound Medical Corp. | 43.68 Million USD | -350.546% |
| Insulet Corporation | 2.58 Billion USD | 92.395% |
| enVVeno Medical Corporation | 48.63 Million USD | -304.702% |
| Surmodics, Inc. | 185.73 Million USD | -5.973% |
| iCAD, Inc. | 41.41 Million USD | -375.221% |
| Nuwellis, Inc. | 9.77 Million USD | -1914.606% |
| Biotricity, Inc. | 5.94 Million USD | -3212.122% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 54.559% |
| Aethlon Medical, Inc. | 8.24 Million USD | -2286.944% |
| InspireMD, Inc. | 47.64 Million USD | -313.129% |
| PAVmed Inc. | 33.11 Million USD | -494.302% |
| BIOLASE, Inc. | 35.1 Million USD | -460.745% |
| Beyond Air, Inc. | 56.96 Million USD | -245.547% |
| FONAR Corporation | 214.24 Million USD | 8.13% |
| Vivani Medical, Inc. | 45.79 Million USD | -329.781% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 30.064% |
| Inari Medical, Inc. | 674.23 Million USD | 70.807% |
| UFP Technologies, Inc. | 404.13 Million USD | 51.297% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -741.193% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -1971.184% |
| Tenon Medical, Inc. | 6.34 Million USD | -3002.08% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -1992.346% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -89.9% |
| AdaptHealth Corp. | 4.61 Billion USD | 95.74% |
| Sintx Technologies, Inc. | 15.36 Million USD | -1181.009% |
| NanoVibronix, Inc. | 6.67 Million USD | -2849.161% |
| Quanterix Corporation | 425.01 Million USD | 53.689% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2014.146% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -266.347% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 88.727% |
| TransMedics Group, Inc. | 706.04 Million USD | 72.123% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -211.475% |
| NeuroMetrix, Inc. | 21.42 Million USD | -818.703% |
| Hyperfine, Inc. | 94.19 Million USD | -108.948% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 26.732% |
| Biomerica, Inc. | 9.25 Million USD | -2026.94% |
| Bone Biologics Corporation | 3.73 Million USD | -5165.904% |
| AVITA Medical, Inc. | 144.33 Million USD | -36.363% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -3942.842% |
| Silk Road Medical, Inc | 265.3 Million USD | 25.812% |